Massachusetts Financial Services Co. MA Increases Holdings in Masimo Corporation $MASI

Massachusetts Financial Services Co. MA increased its position in Masimo Corporation (NASDAQ:MASI) by 6.1% in the third quarter, HoldingsChannel.com reports. The institutional investor owned 2,619,960 shares of the medical equipment provider’s stock after buying an additional 149,567 shares during the quarter. Massachusetts Financial Services Co. MA’s holdings in Masimo were worth $386,575,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Nordea Investment Management AB grew its stake in shares of Masimo by 21.6% during the second quarter. Nordea Investment Management AB now owns 31,868 shares of the medical equipment provider’s stock valued at $5,330,000 after buying an additional 5,659 shares during the last quarter. 4D Advisors LLC boosted its holdings in Masimo by 50.0% during the 2nd quarter. 4D Advisors LLC now owns 45,000 shares of the medical equipment provider’s stock valued at $7,570,000 after acquiring an additional 15,000 shares during the period. Westfield Capital Management Co. LP boosted its holdings in Masimo by 75.9% during the 2nd quarter. Westfield Capital Management Co. LP now owns 1,181,203 shares of the medical equipment provider’s stock valued at $198,702,000 after acquiring an additional 509,724 shares during the period. Geode Capital Management LLC grew its position in Masimo by 6.2% during the 2nd quarter. Geode Capital Management LLC now owns 896,418 shares of the medical equipment provider’s stock worth $150,817,000 after acquiring an additional 52,100 shares during the last quarter. Finally, Strs Ohio increased its stake in Masimo by 39.5% in the 2nd quarter. Strs Ohio now owns 55,983 shares of the medical equipment provider’s stock worth $9,417,000 after purchasing an additional 15,848 shares during the period. 85.96% of the stock is currently owned by institutional investors.

Masimo Stock Up 1.6%

Shares of NASDAQ:MASI opened at $142.05 on Monday. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.92 and a current ratio of 2.84. Masimo Corporation has a 52-week low of $125.94 and a 52-week high of $194.88. The firm has a market capitalization of $7.63 billion, a P/E ratio of -13.48, a P/E/G ratio of 1.45 and a beta of 1.26. The stock has a 50 day moving average price of $139.25 and a 200-day moving average price of $145.93.

Masimo (NASDAQ:MASI) last issued its quarterly earnings results on Tuesday, November 4th. The medical equipment provider reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.12. The company had revenue of $371.20 million for the quarter, compared to analysts’ expectations of $366.89 million. Masimo had a positive return on equity of 33.04% and a negative net margin of 33.20%.The firm’s revenue for the quarter was up 8.2% on a year-over-year basis. During the same period in the prior year, the firm earned $0.86 earnings per share. Masimo has set its FY 2025 guidance at 5.620-5.790 EPS. As a group, equities research analysts anticipate that Masimo Corporation will post 4.1 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

MASI has been the subject of a number of analyst reports. Zacks Research lowered Masimo from a “strong-buy” rating to a “hold” rating in a research note on Friday, October 24th. Needham & Company LLC restated a “hold” rating on shares of Masimo in a research report on Monday, December 1st. Bank of America initiated coverage on Masimo in a research note on Monday, November 17th. They issued a “neutral” rating and a $162.00 target price on the stock. Wall Street Zen upgraded Masimo from a “hold” rating to a “buy” rating in a report on Tuesday, October 14th. Finally, Wells Fargo & Company reiterated an “overweight” rating and issued a $190.00 price objective on shares of Masimo in a report on Friday, December 5th. Four investment analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $189.40.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.